Nasdaq1mon
Lobbying Update: $150,000 of CLENE NANOMEDICINE INC. lobbying was just disclosed
ROBERT DEE ETHERINGTON (Chief Executive Officer) purchased 10,000 shares. DAVID J MATLIN purchased 92,307 shares.
Yahoo Finance1mon
IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS
LOS ANGELES - January 13, 2025 (NEWMEDIAWIRE) - Clene (NASDAQ ... from our expanded access programs," said Clene CEO and President Rob Etherington. "The data are being gathered to support the ...
Mena FN1mon
Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap On Potential Accelerated Pathway For CNM-Au8(R)
and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage ... with the Agency,” said Clene's CEO and President, Rob Etherington.“Clene plans to include the additional ...